Featured projects Duration
Reducing blood culture contamination with the use of a needleless blood draw device (PIVO Pro): An adaptive group sequential randomized controlled trial (the PIVO trial)
investigator-initiated grant from Becton, Dickinson and Company
Comparative effectiveness of interventions to prevent bloodstream infections in central venous catheters: The IVCare adaptive platform trial (IVCare)
National Health and Medical Research Council (NHMRC) Investigator grant (Award ID: 2016399) and Medical Research Future Fund (MRFF) 2023 Clinical Trials Activity grant (Award ID: 2035451)
Reducing blood culture contamination with the use of a needleless blood draw device (PIVO Pro): An adaptive group sequential randomized controlled trial (the PIVO trial)
Becton, Dickinson and Company; Herston Infectious Diseased Institute (HeIDI)
Comparative effectiveness of Class II/III medical devices to prevent bloodstream infections in central venous access devices: The IVCare adaptive platform trial (IVCare)
National Health and Medical Research Council (NHMRC) Investigator grant (Award ID: 2016399) and Medical Research Future Fund (MRFF) 2023 Clinical Trials Activity grant (Award ID: 2035451)